Феохромоцитома і парагангліома. Клінічні настанови Ендокринологічного товариства. Частина 1
Посилання
Agarwal G., Sadacharan D., Aggarwal V. et al. Surgical management of organ-contained unilateral pheochromocytoma: comparative outcomes of laparoscopic and conventional open surgical procedures in a large single-institution series // Langenbecks Arch. Surg. — 2012. — 397. — P. 1109—1116.
Alesina P.F., Hinrichs J., Meier B. et al. Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas // Langenbecks Arch. Surg. — 2012. — 397. — P. 233—238.
Amar L., Bertherat J., Baudin E. et al. Genetic testing in pheochromocytoma or functional paraganglioma // J. Clin. Oncol. — 2005. — 23. — P. 8812—8818.
Amar L., Fassnacht M., Gimenez-Roqueplo A.P. et al. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma // Horm. Metab. Res. — 2012. — 44. — P. 385—389.
Asari R., Scheuba C., Kaczirek K., Niederle B. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A // Arch. Surg. — 2006. — 141. — P. 1199—1205.
Baez J.C., Jagannathan J.P., Krajewski K. et al. Pheochromocytoma and paraganglioma: imaging characteristics // Cancer Imaging. — 2012. — 12. — P. 153—162.
Benhammou J.N., Boris R.S., Pacak K. et al. Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup // J. Urol. — 2010. — 184. — P. 1855—1859.
Benn D.E., Gimenez-Roqueplo A.P., Reilly J.R. et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes // J. Clin. Endocrinol. Metab. — 2006. — 91. — P. 827—836.
Bergamini C., Martellucci J., Tozzi F., Valeri A. Complications in laparoscopic adrenalectomy: the value of experience // Surg. Endosc. — 2011. — 25. — P. 3845—3851.
Brauckhoff M., Gimm O., Thanh P.N. et al. Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy // Surgery. — 2003. — 134. — P. 1020—1027.
Bravo E.L. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma // Endocr. Rev. — 1994. — 15. — P. 356—368.
Briggs R.S., Birtwell A.J., Pohl J.E. Hypertensive response to labetalol in phaeochromocytoma // Lancet. — 1978. — 1. — P. 1045—1046.
Brunaud L., Ayav A., Zarnegar R. et al. Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies // Surgery. — 2008. — 144. — P. 995—1001.
Burnichon N., Rohmer V., Amar L. et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas // J. Clin. Endocrinol. Metab. — 2009. — 94. — P. 2817—2827.
Chew S.L. Recent developments in the therapy of phaeochromocytoma // Expert Opin. Investig. Drugs. — 2004. — 13. — P. 1579—1583.
Combemale F., Carnaille B., Tavernier B. et al. Exclusive use of calcium channel blockers and cardioselective-blockers in the preand per-operative management of pheochromocytomas. 70 cases [in French] // Ann. Chir. — 1998. — 52. — P. 341—345.
Dickson P.V., Alex G.C., Grubbs E.G. et al. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma // Surgery. — 2011. — 150. — P. 452—458.
Eisenhofer G., Huynh T.T., Elkahloun A. et al. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma // Am. J. Physiol. Endocrinol. Metab. — 2008. — 295. — P. E1223—E1233.
Eisenhofer G., Huynh T.T., Hiroi M., Pacak K. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma // Rev. Endocr. Metab. Disord. — 2001. — 2. — P. 297—311.
Eisenhofer G., Lenders J.W., Siegert G. et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status // Eur. J. Cancer. — 2012. — 48. — P. 1739—1749.
Eisenhofer G., Lenders J.W., Timmers H. et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma // Clin. Chem. — 2011. — 57. — P. 411—420.
Eisenhofer G., Pacak K., Huynh T.T. et al. Catecholamine metabolomics and secretory phenotypes in phaeochromocytoma // Endocr. Relat. Cancer. — 2011. — 18. — P. 97—111.
Eisenhofer G., Timmers H.J., Lenders J.W. et al. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location // J. Clin. Endocrinol. Metab. — 2011. — 96. — P. 375—384.
Eisenhofer G., Tischler A.S., de Krijger R.R. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification // Endocr. Pathol. — 2012. — 23. — P. 4—14.
Eisenhofer G., Walther M.M., Huynh T.T. et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes // J. Clin. Endocrinol. Metab. — 2001. — 86. — P. 1999—2008.
Gagner M., Breton G., Pharand D., Pomp A. Is laparoscopic adrenalectomy indicated for pheochromocytomas? // Surgery. — 1996. — 120. — P. 1076—1079.
Gallagher S.F., Wahi M., Haines K.L. et al. Trends in adrenalectomy rates, indications, and physician volume: a statewide analysis of 1816 adrenalectomies // Surgery. — 2007. — 142. — P. 1011—1021.
Gimenez-Roqueplo A.P., Caumont-Prim A., Houzard C. et al. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDH mutation carriers: a multicenter prospective study from the PGL.EVA investigators // J. Clin. Endocrinol. Metab. — 2013. — 98. — P. E162—E173.
Gimenez-Roqueplo A.P., Favier J., Rustin P. et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas // Cancer Res. — 2003. — 63. — P. 5615—5621.
Goers T.A., Abdo M., Moley J.F. et al. Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma // Surg. Endosc. — 2013. — 27. — P. 428—433.
Goldstein R.E., O’Neill J.A.Jr., Holcomb G.W. 3rd et al. Clinical experience over 48 years with pheochromocytoma // Ann. Surg. — 1999. — 229. — P. 755—764.